Uveitis as an immune-related toxicity during checkpoint inhibitor immunotherapy

被引：0
|
作者：
Ayuso, V. Kalinina [1 ]
Ossewaarde-van Norel, J. [1 ]
Kouwenberg, C. [2 ]
Suijkerbuijk, K. P. M. [3 ]
Kuiper, J. J. W. [1 ]
de Boer, J. H. [1 ]
机构：
[1] UMC Utrecht, Dept Ophthalmol, Utrecht, Netherlands
[2] Jeroen Bosch Ziekenhuis, Dept Ophthalmol, sHertogenbosch, Netherlands
[3] UMC Utrecht Canc Ctr, Dept Med Oncol, Utrecht, Netherlands
来源：
ACTA OPHTHALMOLOGICA | 2019年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [41] Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
    Dolladille, Charles
    Ederhy, Stephane
    Sassier, Marion
    Cautela, Jennifer
    Thuny, Franck
    Cohen, Ariel A.
    Fedrizzi, Sophie
    Chretien, Basile
    Da-Silva, Angelique
    Plane, Anne-Flore
    Legallois, Damien
    Milliez, Paul U.
    Lelong-Boulouard, Veronique
    Alexandre, Joachim
    JAMA ONCOLOGY, 2020, 6 (06) : 865 - 871
  • [42] Multiple Gastrointestinal Immune-Related Adverse Events From Immune Checkpoint Inhibitor Therapy
    Barlowe, Trevor S.
    Saxena-Beem, Shruti
    Ishizawar, Rumey C.
    Herfarth, Hans
    Moon, Andrew M.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2024, 15 (11)
  • [43] Phenotyping Hepatic Immune-Related Adverse Events in the Setting of Immune Checkpoint Inhibitor Therapy
    Feldman, Theodore C.
    Kaplan, David E.
    Lin, Albert
    La, Jennifer
    Lee, Jerry S. H.
    Aljehani, Mayada
    Tuck, David P.
    Brophy, Mary T.
    Fillmore, Nathanael R.
    Do, Nhan V.
    JCO CLINICAL CANCER INFORMATICS, 2024, 8
  • [44] Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
    Haratani, Koji
    Hayashi, Hidetoshi
    Nakagawa, Kazuhiko
    BMC MEDICINE, 2020, 18 (01)
  • [45] Immune-Related Thyroiditis with Immune Checkpoint Inhibitors
    Iyer, Priyanka C.
    Cabanillas, Maria E.
    Waguespack, Steven G.
    Hu, Mimi I.
    Thosani, Sonali
    Lavis, Victor R.
    Busaidy, Naifa L.
    Subudhi, Sumit K.
    Diab, Adi
    Dadu, Ramona
    THYROID, 2018, 28 (10) : 1243 - 1251
  • [46] Pulmonary toxicity of immune checkpoint immunotherapy
    Ghanbar, Mohammad I.
    Suresh, Karthik
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (02):
  • [47] Immune Checkpoint Inhibitor-Induced Uveitis
    Cunningham, Emmett T.
    Moorthy, Ramana S.
    Zierhut, Manfred
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2020, 28 (06) : 847 - 849
  • [48] Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology
    Naidoo, Jarushka
    Murphy, Catherine
    Atkins, Michael B.
    Brahmer, Julie R.
    Champiat, Stephane
    Feltquate, David
    Krug, Lee M.
    Moslehi, Javid
    Pietanza, M. Catherine
    Riemer, Joanne
    Robert, Caroline
    Sharon, Elad
    Suarez-Almazor, Maria E.
    Suresh, Karthik
    Turner, Michelle
    Weber, Jeffrey
    Cappelli, Laura C.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (03)
  • [49] Rheumatic Immune-related Adverse Effects from Checkpoint Inhibitor Immunotherapy in Patients with Solid Tumors in a Latin American Population
    Sanchez-Rodriguez, Alain
    Alexandra Rodriguez-Melendez, Elina
    Turrent-Carriles, Alonso
    Bermudez-Bermejo, Paola
    Fabian Martinez-Herrera, Jose
    Gerson-Cwilich, Raquel
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [50] Immune Checkpoint Inhibitor Use in Sepsis: Monitoring Immune Checkpoint Inhibitor Toxicity
    Suresh, Karthik
    D'Alessio, Franco
    CRITICAL CARE MEDICINE, 2019, 47 (09) : E788 - E788
12345